We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Benjamin Chong

Benjamin Chong MD

Assistant Professor, Department of Dermatology at UT Southwestern Medical Center, Director of the UT Southwestern Connective Tissue Disease Clinic, Medical Director of Dermatology at Parkland Memorial Hospital, Dallas, Texas

After graduating with a M.D. at Johns Hopkins School of Medicine in 2004, Dr. Chong pursued dermatology residency training at Henry Ford Hospital in Detroit, MI, where he was selected Chief Resident during his final year. Having completed his dermatology residency and board certification, Dr. Chong joined the Department of Dermatology at UT Southwestern Medical Center as Assistant Instructor in 2008, and was promoted to Assistant Professor in 2009. He is currently the director of the UT Southwestern Connective Tissue Disease Clinic and the Medical Director of Dermatology at Parkland Memorial Hospital.

He is also the principal investigator of the UT Southwestern Cutaneous Lupus Registry, which seeks to better understand the etiology of cutaneous lupus, and improve diagnosis and management of cutaneous lupus. The registry also contains a repository of blood and skin samples, which provides valuable source material for translational research projects. He has authored a total of 26 peer-reviewed journal articles, and four book chapters, and received research funding for his research in cutaneous lupus from the Dermatology Foundation, American College of Rheumatology and Arthritis Foundation, and the National Institute of Health.

Disclosures

He is currently an investigator for Daavlin Corporation.